Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial

Translation, cross-cultural adaptation and reliability of the German version of the migraine disability assessment (MIDAS) questionnaire

(2018) Thomas Benz et al.   Health and Quality of Life Outcomes

On the Metabolism of Exogenous Ketones in Humans

(2017) Brianna J. Stubbs et al.   Frontiers in Physiology

A new way to produce hyperketonemia: Use of ketone ester in a case of Alzheimer's disease

(2015) Mary T. Newport et al.   Alzheimers & Dementia

Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention

(2015) Richard B. Lipton et al.   HEADACHE

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

(2015) Marcelo E Bigal et al.   LANCET NEUROLOGY

Neurological disorders in the Global Burden of Disease 2010 study

(2014) L. J. Stovner et al.   ACTA NEUROLOGICA SCANDINAVICA

Migraine improvement during short lasting ketogenesis: a proof-of-concept study

(2014) C. Di Lorenzo et al.   EUROPEAN JOURNAL OF NEUROLOGY

Riboflavin and migraine: the bridge over troubled mitochondria

(2014) Bruno Colombo et al.   NEUROLOGICAL SCIENCES

Highly efficient ketone body treatment in multiple acyl-CoA dehydrogenase deficiency–related leukodystrophy

(2014) Matthias Gautschi et al.   PEDIATRIC RESEARCH

Epilepsy, energy deficiency and new therapeutic approaches including diet

(2014) Christopher A. Reid et al.   PHARMACOLOGY & THERAPEUTICS

Ketogenic diet in adolescents and adults with epilepsy

(2014) Maromi Nei et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Ketogenic Diet in Neuromuscular and Neurodegenerative Diseases

(2014) Antonio Paoli et al.   Biomed Research International

Global perspectives on the burden of episodic and chronic migraine

(2013) Dawn C Buse et al.   CEPHALALGIA

A decade of the modified Atkins diet (2003–2013): Results, insights, and future directions

(2013) Eric H. Kossoff et al.   EPILEPSY & BEHAVIOR

How Does the Ketogenic Diet Work? Four Potential Mechanisms

(2013) Nika N. Danial et al.   JOURNAL OF CHILD NEUROLOGY

Mitochondrial Dysfunction in Migraine

(2013) William R. Yorns et al.   Seminars in Pediatric Neurology

Medium-chain Triglyceride Ketogenic Diet, An Effective Treatment for Drug-resistant Epilepsy and A Comparison with Other Ketogenic Diets

(2013) Yeou-meiChristiana Liu et al.   Biomedical Journal

CoEnzyme Q10 and Riboflavin: The Mitochondrial Connection

(2012) Herbert G. Markley   HEADACHE

Stimulation of mild, sustained ketonemia by medium-chain triacylglycerols in healthy humans: Estimated potential contribution to brain energy metabolism

(2012) Alexandre Courchesne-Loyer et al.   NUTRITION

Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects

(2012) Kieran Clarke et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

The ketogenic diet: metabolic influences on brain excitability and epilepsy

(2012) Andrew Lutas et al.   TRENDS IN NEUROSCIENCES

The Ketogenic Diet as a Treatment Paradigm for Diverse Neurological Disorders

(2012) Carl E. Stafstrom et al.   Frontiers in Pharmacology

Ketogenic diet in migraine treatment: A brief but ancient history

(2011) Ferdinando Maggioni et al.   CEPHALALGIA

The economic cost of brain disorders in Europe

(2011) J. Olesen et al.   EUROPEAN JOURNAL OF NEUROLOGY

Successful Treatment of Severe Cardiomyopathy in Glycogen Storage Disease Type III With D,L-3-Hydroxybutyrate, Ketogenic and High-Protein Diet

(2011) Vassili Valayannopoulos et al.   PEDIATRIC RESEARCH

Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine

(2010) Min Yang et al.   CEPHALALGIA

Painful Heat Reveals Hyperexcitability of the Temporal Pole in Interictal and Ictal Migraine States

(2010) E. A. Moulton et al.   CEREBRAL CORTEX

Migraine Pain and Nociceptor Activation-Where Do We Stand?

(2010) Dan Levy   HEADACHE

Photophobia in migraine: an interictal PET study of cortical hyperexcitability and its modulation by pain

(2010) N. Boulloche et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Migraine pathogenesis and state of pharmacological treatment options

(2009) Till Sprenger et al.   BMC Medicine

Origin of pain in migraine: evidence for peripheral sensitisation

(2009) Jes Olesen et al.   LANCET NEUROLOGY

Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial

(2009) Samuel T Henderson et al.   Nutrition & Metabolism

Guidelines for Controlled Trials of Prophylactic Treatment of Chronic Migraine in Adults

(2008) S Silberstein et al.   CEPHALALGIA

The ketogenic diet: Uses in epilepsy and other neurologic illnesses

(2008) Kristin W. Barañano et al.   Current Treatment Options in Neurology

Self-Limited Hyperexcitability: Functional Effect of a Familial Hemiplegic Migraine Mutation of the Nav1.1 (SCN1A) Na+ Channel

(2008) S. Cestele et al.   JOURNAL OF NEUROSCIENCE

Effects of short-term and long-term treatment with medium- and long-chain triglycerides ketogenic diet on cortical spreading depression in young rats

(2008) Marcela de Almeida Rabello Oliveira et al.   NEUROSCIENCE LETTERS